Press release
Cancer Treatment Drugs market Growth Analysis on Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1732973/?utm_source=OPEN.com&utm_medium=DC
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
This report studies the global market size of Cancer Treatment Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Treatment Drugs in these regions.
This research report categorizes the global Cancer Treatment Drugs market by top players/brands, region, type and end user. This report also studies the global Cancer Treatment Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Market size by Product
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market size by End User
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Market size by Region
Americas
APAC
Europe
Middle East & Africa
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1732973/?utm_source=OPEN.com&utm_medium=DC
The study objectives of this report are:
To study and analyze the global Cancer Treatment Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Treatment Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Treatment Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Treatment Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cancer Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Treatment Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Cancer Treatment Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Treatment Drugs Market Size Growth Rate by Product
1.4.2 Chemotherapy
1.4.3 Targeted Therapy
1.4.4 Immunotherapy
1.4.5 Hormonal Therapy (Biologic Therapy)
1.4.6 Others
1.5 Market by End User
1.5.1 Global Cancer Treatment Drugs Market Size Growth Rate by End User
1.5.2 Blood Cancer
1.5.3 Breast Cancer
1.5.4 Gastrointestinal Cancer
1.5.5 Prostate Cancer
1.5.6 Respiratory/Lung Cancer
1.5.7 Other Cancers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Treatment Drugs Market Size
2.1.1 Global Cancer Treatment Drugs Revenue 2014-2025
2.1.2 Global Cancer Treatment Drugs Sales 2014-2025
2.2 Cancer Treatment Drugs Growth Rate by Regions
2.2.1 Global Cancer Treatment Drugs Sales by Regions
2.2.2 Global Cancer Treatment Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cancer Treatment Drugs Sales by Manufacturers
3.1.1 Cancer Treatment Drugs Sales by Manufacturers
3.1.2 Cancer Treatment Drugs Sales Market Share by Manufacturers
3.1.3 Global Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Treatment Drugs Revenue by Manufacturers
3.2.1 Cancer Treatment Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Cancer Treatment Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Cancer Treatment Drugs Price by Manufacturers
3.4 Cancer Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cancer Treatment Drugs Sales by Product
4.2 Global Cancer Treatment Drugs Revenue by Product
4.3 Cancer Treatment Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cancer Treatment Drugs Breakdown Data by End User
6 North America
6.1 North America Cancer Treatment Drugs by Countries
6.1.1 North America Cancer Treatment Drugs Sales by Countries
6.1.2 North America Cancer Treatment Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cancer Treatment Drugs by Product
6.3 North America Cancer Treatment Drugs by End User
7 Europe
7.1 Europe Cancer Treatment Drugs by Countries
7.1.1 Europe Cancer Treatment Drugs Sales by Countries
7.1.2 Europe Cancer Treatment Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Treatment Drugs by Product
7.3 Europe Cancer Treatment Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Cancer Treatment Drugs by Countries
8.1.1 Asia Pacific Cancer Treatment Drugs Sales by Countries
8.1.2 Asia Pacific Cancer Treatment Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cancer Treatment Drugs by Product
8.3 Asia Pacific Cancer Treatment Drugs by End User
9 Central & South America
9.1 Central & South America Cancer Treatment Drugs by Countries
9.1.1 Central & South America Cancer Treatment Drugs Sales by Countries
9.1.2 Central & South America Cancer Treatment Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cancer Treatment Drugs by Product
9.3 Central & South America Cancer Treatment Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Cancer Treatment Drugs by Countries
More Details on this Report: https://www.marketstudyreport.com/reports/global-cancer-treatment-drugs-market-insights-forecast-to-2025/?utm_source=OPEN.com&utm_medium=DC
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC.
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Treatment Drugs market Growth Analysis on Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer here
News-ID: 1705869 • Views: …
More Releases from marketstudyreport.com
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders.
Load Bank Market Size was estimated…
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of…
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028.
The operation is done to stop ligament tears and…
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
